393 related articles for article (PubMed ID: 16008596)
1. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
[TBL] [Abstract][Full Text] [Related]
2. Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy.
Bogetti D; Jarzembowski TM; Sankary HN; Manzelli A; Knight PS; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
Transplant Proc; 2005; 37(1):404-6. PubMed ID: 15808659
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
[TBL] [Abstract][Full Text] [Related]
4. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation.
Mehrabi A; Mood ZhA; Sadeghi M; Schmied BM; Müller SA; Welsch T; Kuttymuratov G; Wente MN; Weitz J; Zeier M; Morath Ch; Riediger C; Schemmer P; Encke J; Büchler MW; Schmidt J
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii54-viii60. PubMed ID: 17890265
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation.
St Peter SD; Post DJ; Rodriguez-Davalos MI; Douglas DD; Moss AA; Mulligan DC
Liver Transpl; 2003 Feb; 9(2):144-9. PubMed ID: 12548508
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation.
Bittner HB; Richter M; Kuntze T; Rahmel A; Dahlberg P; Hertz M; Mohr FW
Eur J Cardiothorac Surg; 2006 Feb; 29(2):210-5. PubMed ID: 16386921
[TBL] [Abstract][Full Text] [Related]
7. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.
Deschênes M; Forbes C; Tchervenkov J; Barkun J; Metrakos P; Tector J; Alpert E
Liver Transpl Surg; 1999 Sep; 5(5):357-61. PubMed ID: 10477834
[TBL] [Abstract][Full Text] [Related]
8. Adult ABO-incompatible liver transplantation, using A and B donors.
Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
[TBL] [Abstract][Full Text] [Related]
9. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
10. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
11. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
[TBL] [Abstract][Full Text] [Related]
12. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
Bajjoka I; Hsaiky L; Brown K; Abouljoud M
Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
[TBL] [Abstract][Full Text] [Related]
13. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
Tector AJ; Fridell JA; Mangus RS; Shah A; Milgrom M; Kwo P; Chalasani N; Yoo H; Rouch D; Liangpunsakul S; Herring S; Lumeng L
Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
[TBL] [Abstract][Full Text] [Related]
14. The impact of thymoglobulin on renal function and calcineurin inhibitor initiation in recipients of orthotopic liver transplant: a retrospective analysis of 298 consecutive patients.
Tchervenkov JI; Tzimas GN; Cantarovich M; Barkun JS; Metrakos P
Transplant Proc; 2004; 36(6):1747-52. PubMed ID: 15350468
[TBL] [Abstract][Full Text] [Related]
15. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
16. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
17. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
19. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
Watt KD; Lyden ER; Gulizia JM; McCashland TM
Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation.
Jassem W; Fuggle SV; Cerundolo L; Heaton ND; Rela M
Transplantation; 2006 Jan; 81(2):169-74. PubMed ID: 16436958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
